Procedural advice for orphan medicinal product designation: Guidance for sponsors
Submitted by Anonymous (not verified) on 23 January 2025 - 9:48
Procedural advice for orphan medicinal product designation: Guidance for sponsors
European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey
Submitted by Anonymous (not verified) on 23 January 2025 - 7:52
European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey
Parallel scientific advice processes and special product types
Submitted by Anonymous (not verified) on 22 January 2025 - 16:41
Parallel scientific advice processes and special product types
PSUSA/00001215/202406
Submitted by Anonymous (not verified) on 22 January 2025 - 16:00
PSUSA/00001215/202406
PSUSA/00000463/202404
Submitted by Anonymous (not verified) on 22 January 2025 - 15:59
PSUSA/00000463/202404
PSUSA/00001913/202405
Submitted by Anonymous (not verified) on 22 January 2025 - 15:58
PSUSA/00001913/202405
PSUSA/00010693/202404
Submitted by Anonymous (not verified) on 22 January 2025 - 15:56
PSUSA/00010693/202404
Human medicines European public assessment report (EPAR): Renagel, sevelamer, Date of authorisation: 28/01/2000, Revision: 38, Status: Authorised
Submitted by Anonymous (not verified) on 22 January 2025 - 15:36
Human medicines European public assessment report (EPAR): Renagel, sevelamer, Date of authorisation: 28/01/2000, Revision: 38, Status: Authorised
Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests
Submitted by Anonymous (not verified) on 22 January 2025 - 14:23
Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests
Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa,carbidopa,entacapone, Date of authorisation: 23/08/2011, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 22 January 2025 - 13:41
Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa,carbidopa,entacapone, Date of authorisation: 23/08/2011, Revision: 15, Status: Authorised